Tamoxifen
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Synonyms / Brand Names:Apo-Tamox, Citofen, Crisafeno, Diemon, Gen-Tamoxifen, Istubol, Kessar, Noltam, Nolvadex, Nolvadex-D, Nourytam, Novo-Tamoxifen, Oncomox, PMS-Tamoxifen, Retaxim, Tamizam, Tamofen, Tamone, Tamoxasta, Tamoxen, Tamoxifen citrate, Valodex, Zemide
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Dosing and Administration
For patients with breast cancer, the recommended daily dose is 20-40 mg. Dosages greater than 20 mg per day should be given in divided doses (morning and evening).
For patients with Ductal Carcinoma in Situ (DCIS), the recommended dose is Tamoxifen citrate tablet 20 mg daily for 5 years.
WARNING: For Women with Ductal Carcinoma in Situ (DCIS) and Women at High Risk for Breast Cancer: Serious and life-threatening events associated with Tamoxifen in the risk reduction setting (women at high risk for cancer and women with DCIS) include uterine malignancies, stroke and pulmonary embolism.
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Tamoxifen
Return to top
Publication Resources
Most Recent Articles on Tamoxifen
Review Articles on Tamoxifen
Articles on Tamoxifen in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Tamoxifen
Return to top
Trial Resources
Ongoing Trials with Tamoxifen at Clinical Trials.gov
Trial Results with Tamoxifen
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Tamoxifen
Cochrane Collaboration on Tamoxifen
Cost Effectiveness of Tamoxifen
Return to top
Media Resources
Powerpoint Slides on Tamoxifen
Images of Tamoxifen
Podcasts & MP3s on Tamoxifen
Videos on Tamoxifen
Return to top
Patient Resources
Patient Information from National Library of Medicine
Patient Resources on Tamoxifen
Discussion Groups on Tamoxifen
Patient Handouts on Tamoxifen
Blogs on Tamoxifen
Tamoxifen in the News
Tamoxifen in the Marketplace
Return to top
International Resources
Tamoxifen en Español
Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
